Drug class
Abortifacients
Abortifacients are a pharmacological class of agents used to induce medical termination of pregnancy or facilitate the evacuation of uterine contents in reproductive healthcare. Read more about Abortifacients
71 drugs in this class 55 manufacturers
Drugs in Abortifacients
MISOPROSTOL
CARBOPROST TROMETHAMINE
CARBOPROST TROMETHAMINE
MISOPROSTOL
CARBOPROST TROMETHAMINE
CARBOPROST TROMETHAMINE
OXYTOCIN
DICLOFENAC SODIUM-MISOPROSTOL (diclofenac sodium/misoprostol)
Abortifacients are a pharmacological class of agents used to induce medical termination of pregnancy or facilitate the evacuation of uterine contents in reproductive healthcare.
They function primarily through distinct, complementary mechanisms, such as competitive inhibition of progesterone receptors to detach the gestational sac (e.g., mifepristone) and prostaglandin receptor agonism to stimulate myometrial contractions and cervical softening (e.g., misoprostol).
Therapeutically, these agents are indicated for early pregnancy termination and the medical management of early pregnancy loss or incomplete miscarriage.
-
fda.gov
Abortifacients are a pharmacological class of agents used to induce medical termination of pregnancy or facilitate the evacuation of uterine contents in reproductive healthcare Therapeutically, these agents are indicated for early pregnancy termination and the medical management of early pregnancy loss or incomplete miscarriage
-
nih.gov
Abortifacients are a pharmacological class of agents used to induce medical termination of pregnancy or facilitate the evacuation of uterine contents in reproductive healthcare
-
fda.gov
They function primarily through distinct, complementary mechanisms, such as competitive inhibition of progesterone receptors to detach the gestational sac (e.g., mifepristone) and prostaglandin receptor agonism to stimulate myometrial contractions and cervical softening (e.g., misoprostol)
-
courthousenews.com
They function primarily through distinct, complementary mechanisms, such as competitive inhibition of progesterone receptors to detach the gestational sac (e.g., mifepristone) and prostaglandin receptor agonism to stimulate myometrial contractions and cervical softening (e.g., misoprostol)
-
nih.gov
Therapeutically, these agents are indicated for early pregnancy termination and the medical management of early pregnancy loss or incomplete miscarriage
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.